Related Experiment Video
Updated: Jun 10, 2026

09:32
A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
Tumor markers in clinical practice: General principles and guidelines
1Department of Surgical Oncology, Amrita Institute of Medical Sciences & Research Centre, Ernakulam - 682026, Kerala, India.
Summary
Tumor markers aid cancer care from screening to follow-up but are not diagnostic alone due to nonspecificity. Understanding their role, testing, and interpretation is crucial for effective clinical application.
Area of Science:
- Oncology
- Biochemistry
- Clinical Pathology
Background:
- Tumor markers are increasingly utilized across the cancer care continuum.
- Their effective use requires understanding pathophysiology, detection methods, and interpretation of results.
Purpose of the Study:
- To elucidate the multifaceted role of tumor markers in oncology.
- To highlight the importance of judicious application and understanding limitations.
Main Methods:
- Review of current clinical applications and evidence for tumor markers.
- Discussion of detection techniques and interpretation of serum levels.
Main Results:
- Tumor markers serve in screening, diagnosis, prognosis, and monitoring disease recurrence.
- Nonspecificity limits their use as standalone diagnostic tools.
- Monitoring serum levels can detect recurrence before clinical or radiological evidence.
Conclusions:
- Tumor markers are valuable adjuncts, not definitive diagnostic tools.
- Proper interpretation considering sensitivity, specificity, and prevalence is essential.
- Monitoring trends in serum levels is a key application for detecting recurrence.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
